Adil Harroud,Ahmad Almutlaq,David Pellerin et al.
Adil Harroud et al.
Neuromyelitis optica spectrum disorders with unevenly clustered attack occurrence [0.03%]
发作呈集群分布的视神经脊髓炎谱系病临床分析
Tetsuya Akaishi,Ichiro Nakashima,Toshiyuki Takahashi et al.
Tetsuya Akaishi et al.
Objective: The aim of this study was to elucidate the characteristics of clinical attacks in neuromyelitis optica spectrum disorders (NMOSDs) with positive serum anti-aquaporin-4 antibody. Both the timing and sequential p...
An argument for broad use of high efficacy treatments in early multiple sclerosis [0.03%]
关于在早期多发性硬化症中广泛使用高效能治疗的论证
James M Stankiewicz,Howard L Weiner
James M Stankiewicz
Two different treatment paradigms are most often used in multiple sclerosis (MS). An escalation or induction approach is considered when treating a patient early in the disease course. An escalator prioritizes safety, whereas an inducer wou...
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype [0.03%]
慢性炎症性脱髓鞘性多发性神经病中针对神经基质蛋白的自身抗体：IgG亚类的临床意义
Andrea Cortese,Raffaella Lombardi,Chiara Briani et al.
Andrea Cortese et al.
Objective: To assess the prevalence and isotypes of anti-nodal/paranodal antibodies to nodal/paranodal proteins in a large chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) cohort, compare clinical features...
Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions [0.03%]
利妥昔单抗经乳汁传递的量极低：一种用于治疗神经疾病的单克隆抗体
Kristen M Krysko,Sara C LaHue,Annika Anderson et al.
Kristen M Krysko et al.
Objective: To determine the transfer of rituximab, an anti-CD20 monoclonal antibody widely used for neurologic conditions, into mature breast milk. Method...
A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS [0.03%]
一例多中心型Castleman病伴发多发性硬化症患者的Alemtu单抗治疗病例
Leoni Rolfes,Steffen Pfeuffer,Tobias Ruck et al.
Leoni Rolfes et al.
Black African and Latino/a identity correlates with increased plasmablasts in MS [0.03%]
黑非人和拉丁裔身份与MS中增多的浆细胞相关
Kiel M Telesford,Ulrike W Kaunzner,Jai Perumal et al.
Kiel M Telesford et al.
Objective: To determine the influence of self-reported Black African and Latin American identity on peripheral blood antibody-secreting cell (ASC) frequency in the context of relapsing-remitting MS. ...
Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab [0.03%]
阿仑单抗治疗后淋巴细胞药动学与自身免疫和疗效无关
Heinz Wiendl,Matthew Carraro,Giancarlo Comi et al.
Heinz Wiendl et al.
Objective: To examine the association between peripheral blood lymphocyte pharmacodynamics and autoimmune adverse events (AEs) or return of disease activity in alemtuzumab-treated patients with relapsing-remitting MS. ...